Surrozen, Inc./DE (SRZN) reporting calendar
Surrozen, Inc./DE files periodic reports with the SEC as SRZN on Nasdaq. Atlas tracks 23 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 12 Jul 2026 – 4 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 6 May 2026
- Reports on record
- 23
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 39 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open SRZN market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 6 May 2026 | 36 days | 0001193125-26-209179 |
| 10-K | 31 Dec 2025 | 23 Mar 2026 | 82 days | 0001193125-26-119818 |
| 10-Q | 30 Sep 2025 | 7 Nov 2025 | 38 days | 0001193125-25-272422 |
| 10-Q | 30 Jun 2025 | 8 Aug 2025 | 39 days | 0000950170-25-105847 |
| 10-Q | 31 Mar 2025 | 9 May 2025 | 39 days | 0000950170-25-068046 |
| 10-K | 31 Dec 2024 | 31 Mar 2025 | 90 days | 0000950170-25-047712 |
| 10-Q | 30 Sep 2024 | 6 Nov 2024 | 37 days | 0000950170-24-122318 |
| 10-Q | 30 Jun 2024 | 12 Aug 2024 | 43 days | 0000950170-24-095443 |
| 10-Q | 31 Mar 2024 | 8 May 2024 | 38 days | 0000950170-24-055706 |
| 10-K | 31 Dec 2023 | 10 Apr 2024 | 101 days | 0000950170-24-043399 |
| 10-Q | 30 Sep 2023 | 8 Nov 2023 | 39 days | 0000950170-23-061150 |
| 10-Q | 30 Jun 2023 | 9 Aug 2023 | 40 days | 0000950170-23-040648 |
| 10-Q | 31 Mar 2023 | 10 May 2023 | 40 days | 0000950170-23-020618 |
| 10-K | 31 Dec 2022 | 31 Mar 2023 | 90 days | 0000950170-23-011118 |
| 10-Q | 30 Sep 2022 | 14 Nov 2022 | 45 days | 0000950170-22-025096 |
| 10-Q | 30 Jun 2022 | 11 Aug 2022 | 42 days | 0000950170-22-016889 |
| 10-Q | 31 Mar 2022 | 11 May 2022 | 41 days | 0000950170-22-009343 |
| 10-K | 31 Dec 2021 | 28 Mar 2022 | 87 days | 0000950170-22-004787 |
| 10-Q | 30 Sep 2021 | 15 Nov 2021 | 46 days | 0000950170-21-004618 |
| 10-Q | 30 Jun 2021 | 9 Aug 2021 | 40 days | 0001193125-21-239469 |
| 10-Q | 31 Mar 2021 | 24 May 2021 | 54 days | 0001193125-21-169878 |
| 10-K | 31 Dec 2020 | 31 Mar 2021 | 90 days | 0001104659-21-044518 |
| 10-Q | 30 Sep 2020 | 4 Jan 2021 | 96 days | 0001104659-21-000285 |
Source: SEC EDGAR company submissions for CIK 0001824893. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.